SectorPharmaceutical
Established Date29/04/2008
Listing Date18/11/2021
ExchangeNew York Stock Exchange
Full-time Employees8
Fiscal Year Ends31/12
Security TypeCommon stock
Office address101 Lindenwood Drive, Suite 225, Malvern, PA 19355
Business
IntroductionAnnovis Bio, Inc., was incorporated under the laws of the State of Delaware on April 29, 2008. Annovis is a clinical-stage pharmaceutical company focused on the development and commercialization of innovative medicines for the treatment of Parkinson's disease (" PD ") and Alzheimer's disease (" AD ") and neurodegenerative diseases. The company's lead compound, ANVS-401, is a neurochemical nerve defect therapy that inhibits neurodegeneration and inhibits the conversion of neurotoxic proteins into adults and normalized axonal vesicle transport.
